Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Neurology Physician in Laguna Niguel, CA
NPI: 1467482216Primary Employer
MS Center of Southern California
mscenterofcalifornia.com
HQ Phone
Get M.D. Daniel's Phone NumberMobile
Get M.D. Daniel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2003 - 2027
University of Southern California/LAC+USC Medical Center
Fellowship • Neuroimmunology & Multiple Sclerosis
2004 - 2006
Kaiser Permanente Southern California (Los Angeles)
Residency • Neurology
2000 - 2004
American University of the Caribbean School of Medicine
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 120 | 464 |
| 2 | 95874Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | 15 | 74 |
| 3 | 64644Injection of chemical for destruction of nerve muscles on arm or leg, 5 or more muscles | 15 | 74 |
| 4 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 12 | 48 |
| 5 | J0588Injection, incobotulinumtoxin a, 1 unit | 11 | 16,900 |
Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis.
Authors: Bianca Weinstock Guttman, Pavle Repovic, Mark Gudesblatt, Bhupendra Khatri, Mariko Kita, Sherrill Loring, Ben Thrower, Jeffrey Greenstein
Publication Date: 2019-11-14
Authors: Theodore Chan
Journal: J Manag Care Pharm
Authors: Gerard Francisco, Alberto Esquenazi, Alberto Esquenazi
Journal: PM R
Publication Date: 2016-09-24
Lead Sponsor: MedDay Pharmaceuticals SA
Intervention / Treatment: DRUG: PLACEBO, DRUG: MD1003 100mg capsule
Lead Sponsor: Oregon Health and Science University
Collaborators: University of Southern California, Forest Laboratories, University of Texas Southwestern Medical Center, MS-Hub Seattle
Intervention / Treatment: DRUG: Memantine
Lead Sponsor: Sanofi
Intervention / Treatment: DRUG: Placebo, DRUG: Tolebrutinib